No Detail Found!

In vitro efficacy of Linezolid against vancomycin resistant Enterococci.

Author(s)
Muhammad Shahbaz Hussain Department of Pathology, Sheikh Zayed Medical College/Hospital Rahim Yar Khan,Pakistan
Azfar Sattar Department of Pathology, Aziz Fatima Medical College Faisalabad,Pakistan
Mazhar Hussain Department of Pharmacology, Sheikh Zayed Medical College/Hospital Rahim Yar Khan,Pakistan
Abstract
Vancomycin-resistance among Enterococci has been escalating in recent years in many countries. Linezolid, an oxazolidinone is one of the novel drug that promised effective therapy of infections caused by vancomycin-resistant Enterococci (VRE).However, like with most of the previous antimicrobial agents, the clinical benefit of linezolid is being threatened by the emergence of resistant strains of MRSA and vancomycin resistant enterococci VRE, being reported in many countries. This study was conducted to establish linezolid susceptibility of VRE isolates by determining the in vitro activity of linezolid against vancomycin resistant Enterococci, isolated in our setup using fifty VRE isolates. The data collected from this study conclude that the vancomycin resistant Enterococci are 100% linezolid susceptible and presently there is no significant resistance against this unique oxazolidinone in our setup.
Publication Details
Page(s) 1853-1857
DOI DOI not available
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 31, Issue: 5, Year: 2018

Request the full text from PASTIC

0

Citations

0

Downloads

105

Views